FDA Inspection
Pfizer Ireland Pharmaceuticals Unlimited CompanyFDA Inspection 857677 - Pfizer Ireland Pharmaceuticals Unlimited Company - October 15, 2013
Record Details
This FDA Inspection record concerns Pfizer Ireland Pharmaceuticals Unlimited Company, with an inspection on October 15, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- October 15, 2013
- Product Type
- Drugs
View Company Profile
ID · c36f43df-2ec0-4ff1-8a8e-6f1fdafc70b2
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 857677
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Pfizer Ireland Pharmaceuticals Unlimited Company
12| Date | Classification | Office | Project area |
|---|---|---|---|
| December 15, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 11, 2023 | Not classified | Office of Inspections and Investigations | |
| January 24, 2023 | Not classified | Office of Inspections and Investigations | |
| November 12, 2019 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| November 9, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Pfizer Ireland Pharmaceuticals Unlimited Company
- FDA Inspection 1270977 - 2023-12-15
- FDA Inspection 1208210 - 2023-05-11
- FDA Inspection 1201722 - 2023-01-24
- FDA Inspection 1109599 - 2019-11-12
- FDA Inspection 1112255 - 2018-11-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.